Beneficial Effects of Tyrosol and Oleocanthal from Extra Virgin Olive Oil on Liver Health: Insights into Their Mechanisms of Action

被引:0
|
作者
Gabbia, Daniela [1 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy
来源
BIOLOGY-BASEL | 2024年 / 13卷 / 10期
关键词
tyrosol; oleocanthal; extra virgin olive oil; chronic liver disease; fibrosis; hepatocellular carcinoma; metabolic dysfunction-associated steatotic liver disease; metabolic dysfunction-associated steatohepatitis; MEDITERRANEAN DIET; METABOLIC SYNDROME; PHENOLIC-COMPOUNDS; LIPID-METABOLISM; ANTIOXIDANT; DISEASE; HYDROXYTYROSOL; CANCER; IMPACT; MODULATION;
D O I
10.3390/biology13100760
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Consumption of extra virgin olive oil (EVOO) is associated with many beneficial effects on human health as a result of its phenolic-derived compounds. This review explores the hepatoprotective properties and mechanisms of action of tyrosol and oleocanthal from extra virgin olive oil. Both compounds demonstrate antioxidant, anti-inflammatory, and modulatory effects on liver metabolism that improve chronic liver diseases, such as dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis, and their progression to liver cancer. Mechanistic studies have suggested that these compounds exert their hepatoprotective effects through the regulation of multiple cellular pathways, including those involved in the antioxidant response and lipid metabolism. Understanding these mechanisms may provide valuable information for the development of therapeutic agents based on their chemical structures that are useful to improve liver health and prevent liver-related disorders.Abstract The Mediterranean diet and consumption of EVOO are associated with multiple beneficial effects for human health, e.g. reduction in cardiovascular risk and mortality, improvement in the lipid profile, and the prevention of chronic diseases, such as cancers and neurodegenerative diseases. In EVOO, more than 30 different phenolic-derived compounds have been identified, representing one of the most promising bioactive classes in olive oil. This review explores the hepatoprotective properties of two of these compounds, tyrosol and oleocanthal, focusing on their mechanisms of action. Recent studies have shown that these compounds, which share a similar chemical structure with a hydroxyl group attached to an aromatic hydrocarbon ring, can potentially mitigate chronic liver diseases, such as MASLD and liver fibrosis, as well as their progression to liver cancer. Consequently, they deserve attention for future pharmacological drug development. In vitro and in vivo studies have suggested that these compounds exert these effects through the regulation of cellular pathways involved in antioxidant response, lipid metabolism, transcription factor activity, and NF-kappa B signaling. Understanding the mechanisms underlying the hepatoprotective properties of tyrosol and oleocanthal may provide valuable information for the development of therapeutic agents based on their chemical structures capable of targeting chronic liver diseases.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Protein suppresses both bitterness and oleocanthal-elicited pungency of extra virgin olive oil
    des Gachons, Catherine Peyrot
    O'Keefe, Abigail J.
    Slade, Louise
    Beauchamp, Gary K.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component
    Monti, Maria Chiara
    Margarucci, Luigi
    Tosco, Alessandra
    Riccio, Raffaele
    Casapullo, Agostino
    FOOD & FUNCTION, 2011, 2 (07) : 423 - 428
  • [23] Evaluation of lignans and free and linked hydroxy-tyrosol and tyrosol in extra virgin olive oil after hydrolysis processes
    Mulinacci, N
    Giaccherini, C
    Ieri, F
    Innocenti, M
    Romani, A
    Vincieri, FF
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2006, 86 (05) : 757 - 764
  • [24] Unusual Pungency from Extra-Virgin Olive Oil Is Attributable to Restricted Spatial Expression of the Receptor of Oleocanthal
    des Gachons, Catherine Peyrot
    Uchida, Kunitoshi
    Bryant, Bruce
    Shima, Asako
    Sperry, Jeffrey B.
    Dankulich-Nagrudny, Luba
    Tominaga, Makoto
    Smith, Amos B., III
    Beauchamp, Gary K.
    Breslin, Paul A. S.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (03): : 999 - 1009
  • [25] Insights into the Analysis of Phenolic Secoiridoids in Extra Virgin Olive Oil
    Celano, Rita
    Piccinelli, Anna Lisa
    Pugliese, Alessandro
    Carabetta, Sonia
    di Sanzo, Rosa
    Rastrelli, Luca
    Russo, Mariateresa
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (24) : 6053 - 6063
  • [26] Anti-Biofilm Activity of Oleacein and Oleocanthal from Extra-Virgin Olive Oil toward Pseudomonas aeruginosa
    Di Pietro, Marisa
    Filardo, Simone
    Mattioli, Roberto
    Bozzuto, Giuseppina
    Raponi, Giammarco
    Mosca, Luciana
    Sessa, Rosa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [27] Short Lecture "New insights into the mechanism of action and bioavailability of oleocanthal and oleacein from olive oil"
    Kalyva, F.
    Diamantakos, P.
    Melliou, E.
    Nikolantonaki, M.
    Magiatis, P.
    PLANTA MEDICA, 2022, 88 (15) : 1423 - 1423
  • [28] Oleocanthal and Oleacein from Privet Leaves: An Alternative Source for High-Value Extra Virgin Olive Oil Bioactives
    des Gachons, Catherine Peyrot
    Willis, Claudia
    Napolitano, Michael P.
    O'Keefe, Abigail J.
    Kimball, Bruce A.
    Slade, Louise
    Beauchamp, Gary K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [29] Anti-Proliferative Effects of an Extra-Virgin Olive Oil Extract Enriched in Ligstroside Aglycone and Oleocanthal on Human Liver Cancer Cell Lines
    De Stefanis, Daniela
    Scime, Salvatore
    Accomazzo, Simone
    Catti, Andrea
    Occhipinti, Andrea
    Bertea, Cinzia Margherita
    Costelli, Paola
    CANCERS, 2019, 11 (11)
  • [30] Bioactive minor compounds of extra-virgin olive oil: the ibuprofen-like activity of oleocanthal
    Galli, C
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2006, 108 (02) : 95 - 96